• 文献检索
  • 文档翻译
  • 深度研究
  • 学术资讯
  • Suppr Zotero 插件Zotero 插件
  • 邀请有礼
  • 套餐&价格
  • 历史记录
应用&插件
Suppr Zotero 插件Zotero 插件浏览器插件Mac 客户端Windows 客户端微信小程序
定价
高级版会员购买积分包购买API积分包
服务
文献检索文档翻译深度研究API 文档MCP 服务
关于我们
关于 Suppr公司介绍联系我们用户协议隐私条款
关注我们

Suppr 超能文献

核心技术专利:CN118964589B侵权必究
粤ICP备2023148730 号-1Suppr @ 2026

文献检索

告别复杂PubMed语法,用中文像聊天一样搜索,搜遍4000万医学文献。AI智能推荐,让科研检索更轻松。

立即免费搜索

文件翻译

保留排版,准确专业,支持PDF/Word/PPT等文件格式,支持 12+语言互译。

免费翻译文档

深度研究

AI帮你快速写综述,25分钟生成高质量综述,智能提取关键信息,辅助科研写作。

立即免费体验

木犀草素对糖尿病及其并发症的治疗潜力

Therapeutic Potential of Luteolin for Diabetes Mellitus and Its Complications.

作者信息

Chang Xiao-Qin, Yue Ren-Song

机构信息

Endocrinology Department, Affiliated Hospital of Chengdu University of Traditional Chinese Medicine, Chengdu, 610075, China.

出版信息

Chin J Integr Med. 2025 Jun;31(6):566-576. doi: 10.1007/s11655-024-3917-z. Epub 2024 Sep 20.

DOI:10.1007/s11655-024-3917-z
PMID:39302570
Abstract

The global prevalence of diabetes mellitus (DM) and its complications has been showing an upward trend in the past few decades, posing an increased economic burden to society and a serious threat to human life and health. Therefore, it is urgent to investigate the effectiveness of complementary and alternative therapies for DM and its complications. Luteolin is a kind of polyphenol flavonoid with widely existence in some natural resources, as a safe dietary supplement, it has been widely studied and reported in the treatment of DM and its complications. This review demonstrates the therapeutic potential of luteolin in DM and its complications, and elucidates the action mode of luteolin at the molecular level. It is characterized by anti-inflammatory, antioxidant, and neuroprotective effects. In detail, luteolin can not only improve endothelial function, insulin resistance and β-cell dysfunction, but also inhibit the activities of dipeptidyl peptidase-4 and α-glucosidase. However, due to the low water solubility and oral bioavailability of luteolin, its application in the medical field is limited. Therefore, great importance should be attached to the joint application of luteolin with current advanced science and technology. And more high-quality human clinical studies are needed to clarify the effects of luteolin on DM patients.

摘要

在过去几十年中,全球糖尿病(DM)及其并发症的患病率呈上升趋势,给社会带来了日益加重的经济负担,并对人类生命和健康构成严重威胁。因此,迫切需要研究补充和替代疗法对DM及其并发症的有效性。木犀草素是一种广泛存在于某些自然资源中的多酚类黄酮,作为一种安全的膳食补充剂,它在DM及其并发症的治疗方面已得到广泛研究和报道。本综述展示了木犀草素在DM及其并发症中的治疗潜力,并阐明了木犀草素在分子水平上的作用模式。其特点是具有抗炎、抗氧化和神经保护作用。具体而言,木犀草素不仅可以改善内皮功能、胰岛素抵抗和β细胞功能障碍,还能抑制二肽基肽酶-4和α-葡萄糖苷酶的活性。然而,由于木犀草素的水溶性和口服生物利用度较低,其在医学领域的应用受到限制。因此,应高度重视木犀草素与当前先进科学技术的联合应用。并且需要更多高质量的人体临床研究来阐明木犀草素对DM患者的影响。

相似文献

1
Therapeutic Potential of Luteolin for Diabetes Mellitus and Its Complications.木犀草素对糖尿病及其并发症的治疗潜力
Chin J Integr Med. 2025 Jun;31(6):566-576. doi: 10.1007/s11655-024-3917-z. Epub 2024 Sep 20.
2
Diabetes and its Complications: Role of Luteolin, A Wonder Chemical from the Natural Source.糖尿病及其并发症:天然来源的神奇化学物质——木樨草素的作用。
Curr Diabetes Rev. 2024;21(1):e290224227537. doi: 10.2174/0115733998285798240217084632.
3
Antioxidant and antiinflammatory activities of curcumin on diabetes mellitus and its complications.姜黄素对糖尿病及其并发症的抗氧化和抗炎活性。
Curr Pharm Des. 2013;19(11):2101-13.
4
Luteolin protects against diabetic cardiomyopathy by inhibiting NF-κB-mediated inflammation and activating the Nrf2-mediated antioxidant responses.木犀草素通过抑制 NF-κB 介导的炎症反应和激活 Nrf2 介导的抗氧化反应来保护糖尿病心肌病。
Phytomedicine. 2019 Jun;59:152774. doi: 10.1016/j.phymed.2018.11.034. Epub 2018 Nov 28.
5
Isoorientin: A dietary flavone with the potential to ameliorate diverse metabolic complications.异甘草素:一种具有改善多种代谢并发症潜力的膳食类黄酮。
Pharmacol Res. 2020 Aug;158:104867. doi: 10.1016/j.phrs.2020.104867. Epub 2020 May 11.
6
Luteolin ameliorates cardiac failure in type I diabetic cardiomyopathy.木犀草素可改善 I 型糖尿病心肌病心力衰竭。
J Diabetes Complications. 2012 Jul-Aug;26(4):259-65. doi: 10.1016/j.jdiacomp.2012.04.007. Epub 2012 May 23.
7
Regulatory Role of NF-κB on HDAC2 and Tau Hyperphosphorylation in Diabetic Encephalopathy and the Therapeutic Potential of Luteolin.NF-κB 对糖尿病脑病中 HDAC2 和 Tau 过度磷酸化的调控作用及木犀草素的治疗潜力。
Diabetes. 2024 Sep 1;73(9):1513-1526. doi: 10.2337/db23-0969.
8
Bioavailability and Pharmaco-therapeutic Potential of Luteolin in Overcoming Alzheimer's Disease.木犀草素在攻克阿尔茨海默病方面的生物利用度及药物治疗潜力
CNS Neurol Disord Drug Targets. 2019;18(5):352-365. doi: 10.2174/1871527318666190319141835.
9
Effect of luteoin in delaying cataract in STZ-induced diabetic rats.叶黄素对链脲佐菌素诱导的糖尿病大鼠白内障的影响。
Arch Pharm Res. 2017 Jan;40(1):88-95. doi: 10.1007/s12272-015-0669-5. Epub 2015 Oct 13.
10
Beneficial effects of resveratrol on diabetes mellitus and its complications: focus on mechanisms of action.白藜芦醇对糖尿病及其并发症的有益作用:聚焦作用机制
Naunyn Schmiedebergs Arch Pharmacol. 2025 Mar;398(3):2407-2442. doi: 10.1007/s00210-024-03527-4. Epub 2024 Oct 24.

引用本文的文献

1
Luteolin Nanomedicine with Stimulus-Driven Traceless Release for Targeting Treatment of Atherosclerosis by Enhancing Lipid Efflux.具有刺激驱动无痕释放功能的木犀草素纳米药物,通过增强脂质外流靶向治疗动脉粥样硬化
Research (Wash D C). 2025 Jul 11;8:0754. doi: 10.34133/research.0754. eCollection 2025.
2
Antioxidative and Anticancer Potential of Luteolin: A Comprehensive Approach Against Wide Range of Human Malignancies.木犀草素的抗氧化和抗癌潜力:针对多种人类恶性肿瘤的综合方法
Food Sci Nutr. 2025 Jan 19;13(1):e4682. doi: 10.1002/fsn3.4682. eCollection 2025 Jan.

本文引用的文献

1
Luteolin Mitigates Diabetic Dyslipidemia in Rats by Modulating ACAT-2, PPARα, SREBP-2 Proteins, and Oxidative Stress.木樨草素通过调节 ACAT-2、PPARα、SREBP-2 蛋白和氧化应激减轻大鼠糖尿病血脂异常。
Appl Biochem Biotechnol. 2023 Aug;195(8):4893-4914. doi: 10.1007/s12010-023-04544-4. Epub 2023 Apr 27.
2
Evaluation of Antidiabetic Effect of Luteolin in STZ Induced Diabetic Rats: Molecular Docking, Molecular Dynamics, In Vitro and In Vivo Studies.木犀草素对链脲佐菌素诱导的糖尿病大鼠的抗糖尿病作用评估:分子对接、分子动力学、体外和体内研究
J Funct Biomater. 2023 Feb 25;14(3):126. doi: 10.3390/jfb14030126.
3
Luteolin intake is negatively associated with all-cause and cardiac mortality among patients with type 2 diabetes mellitus.
在2型糖尿病患者中,摄入木犀草素与全因死亡率和心脏死亡率呈负相关。
Diabetol Metab Syndr. 2023 Mar 25;15(1):59. doi: 10.1186/s13098-023-01026-9.
4
The protection of luteolin against diabetic cardiomyopathy in rats is related to reversing JNK-suppressed autophagy.木犀草素对大鼠糖尿病性心肌病的保护作用与逆转JNK抑制的自噬有关。
Food Funct. 2023 Mar 20;14(6):2740-2749. doi: 10.1039/d2fo03871d.
5
Luteolin-7-O-rutinoside Protects RIN-5F Cells from High-Glucose-Induced Toxicity, Improves Glucose Homeostasis in L6 Myotubes, and Prevents Onset of Type 2 Diabetes.木犀草素-7-O-芸香糖苷可保护RIN-5F细胞免受高糖诱导的毒性,改善L6肌管中的葡萄糖稳态,并预防2型糖尿病的发生。
Metabolites. 2023 Feb 14;13(2):269. doi: 10.3390/metabo13020269.
6
A Nutraceutical Containing Chlorogenic Acid and Luteolin Improves Cardiometabolic Parameters in Subjects with Pre-Obesity: A 6-Month Randomized, Double-Blind, Placebo-Controlled Study.一种含有绿原酸和木樨草素的营养保健品可改善肥胖前期人群的心血代谢参数:一项为期 6 个月的随机、双盲、安慰剂对照研究。
Nutrients. 2023 Jan 16;15(2):462. doi: 10.3390/nu15020462.
7
Recent Updates on Source, Biosynthesis, and Therapeutic Potential of Natural Flavonoid Luteolin: A Review.天然黄酮木犀草素的来源、生物合成及治疗潜力的最新进展:综述
Metabolites. 2022 Nov 20;12(11):1145. doi: 10.3390/metabo12111145.
8
Luteolin loaded on zinc oxide nanoparticles ameliorates non-alcoholic fatty liver disease associated with insulin resistance in diabetic rats regulation of PI3K/AKT/FoxO1 pathway.锌氧化物纳米载芦丁可改善糖尿病大鼠非酒精性脂肪肝疾病并伴有胰岛素抵抗 通过调控 PI3K/AKT/FoxO1 信号通路。
Int J Immunopathol Pharmacol. 2022 Jan-Dec;36:3946320221137435. doi: 10.1177/03946320221137435.
9
Evaluation of Diabetes Effects of Selenium Nanoparticles Synthesized from a Mixture of Luteolin and Diosmin on Streptozotocin-Induced Type 2 Diabetes in Mice.评价芦丁和地奥司明混合物合成的硒纳米粒子对链脲佐菌素诱导的 2 型糖尿病小鼠的糖尿病作用。
Molecules. 2022 Sep 1;27(17):5642. doi: 10.3390/molecules27175642.
10
The challenge of flavonoid/cyclodextrin complexation in a complex matrix of the quercetin, luteolin, and 3--methylquercetin.槲皮素、木樨草素和 3-甲基槲皮素在复杂基质中与环糊精形成复合物的挑战。
Pharm Dev Technol. 2022 Jul;27(6):625-634. doi: 10.1080/10837450.2022.2098326. Epub 2022 Jul 11.